The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Association Between Pentavalent Rotavirus Vaccine and Severe Rotavirus Diarrhea Among Children in Nicaragua
Abstract
CONTEXT: Pentavalent rotavirus vaccine (RV5), a live, oral attenuated vaccine, prevented 98% of severe rotavirus diarrhea in a trial conducted mainly in Finland and the United States. Nicaragua introduced RV5 in 2006, providing the first opportunity to assess the association between vaccination and rotavirus disease in a developing country. OBJECTIVE: To assess the association between RV5 vaccination and subsequent rotavirus diarrhea requiring overnight admission or intravenous hydration. DESIGN, SETTING, AND PARTICIPANTS: Case-control evaluation in 4 hospitals in Nicaragua from June 2007 to June 2008. Cases were children age-eligible to receive RV5 who were admitted or required intravenous hydration for laboratory-confirmed rotavirus diarrhea. For each case (n = 285), 1 to 3 neighborhood (n = 840) and hospital (n = 690) controls were selected. MAIN OUTCOME MEASURES: Primary outcome was the association of RV5 and rotavirus diarrhea requiring overnight admission or intravenous hydration in the emergency department. Secondary analysis further classified disease as severe and very severe. We computed the matched odds ratio of vaccination in cases vs controls. Vaccine effectiveness was estimated using the formula 1 - matched odds ratio x 100%. RESULTS: Of the 285 rotavirus cases, 265 (93%) required hospitalization; 251 (88%) received intravenous hydration. A single rotavirus strain (G2P[4]) was identified in 88% of the cases. Among cases and controls, respectively, 18% and 12% were unvaccinated, 12% and 15% received 1 dose of RV5, 15% and 17% received 2 doses, and 55% and 57% received 3 doses. Vaccination with 3 doses was associated with a lower risk of rotavirus diarrhea requiring overnight admission or intravenous hydration (odds ratio [OR], 0.54; 95% confidence interval [CI], 0.36-0.82). Of the 285 rotavirus cases, 191 (67%) were severe and 54 (19%) were very severe. A progressively lower risk of severe (OR, 0.42; 95% CI, 0.26-0.70) and very severe rotavirus diarrhea (OR, 0.23; 95% CI, 0.08-0.61) was observed after RV5 vaccination. Thus, effectiveness of 3 doses of RV5 against rotavirus disease requiring admission or treatment with intravenous hydration was 46% (95% CI, 18%-64%); against severe rotavirus diarrhea, 58% (95% CI, 30%-74%); and against very severe rotavirus diarrhea, 77% (95% CI, 39%-92%). CONCLUSION: Vaccination with RV5 was associated with a lower risk of severe rotavirus diarrhea in children younger than 2 years in Nicaragua but to a lesser extent than that seen in clinical trials in industrialized countries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Global Illness and Deaths Caused by Rotavirus Disease in Children
Parashar, U. D., Hummelman, E. G., Bresee, J. S., Miller, M. A., & Glass, R. I. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0905.020562 · Cited by 1,898
Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine
Vesikari, T., Matson, D. O., Dennehy, P., Van Damme, P., Santosham, M., Rodriguez, Z., Dallas, M. J., Heyse, J. F., Goveia, M. G., Black, S. B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052664 · Cited by 1,873
Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis
Ruiz-Palacios, G. M., Pérez-Schael, I., Velázquez, F. R., Abate, H., Breuer, T., Clemens, S. C., Cheuvart, B., Espinoza, F., Gillard, P., Innis, B. L., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052434 · Cited by 1,799
Rotavirus and Severe Childhood Diarrhea
Parashar, U. D., Gibson, C. J., Bresee, J. S., & Glass, R. I. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1202.050006 · Cited by 1,470
Identification of group A rotavirus gene 4 types by polymerase chain reaction
Gentsch, J. R., Glass, R. I., Woods, P. A., Gouvêa, V., Gorziglia, M. I., Flores, J., Das, B. K., & Bhan, M. K. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.6.1365-1373.1992 · Cited by 1,401
Rotavirus gene structure and function.
Estes, M. K., & Cohen, J. (1989) · Microbiological Reviews · doi:10.1128/mmbr.53.4.410-449.1989 · Cited by 885
Ruuska, T., & Vesikari, T. (1990) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549009027046 · Cited by 714
Rotavirus infection in infants as protection against subsequent infections
(1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)80038-8 · Cited by 674
Gentsch, J. R., Laird, A. R., Bielfelt, B., Griffin, D. D., Bányai, K., Ramachandran, M., Jain, V., Cunliffe, N. A., Nakagomi, O., Kirkwood, C. D., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/431499 · Cited by 624
Rotavirus vaccines: current prospects and future challenges
Glass, R. I., Parashar, U. D., Bresee, J. S., Turcios, R., Fischer, T. K., Widdowson, M.-A., Jiang, B., & Gentsch, J. R. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68815-6 · Cited by 482
Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: Review.
Patriarca, P. A., Wright, P. F., & John, T. J. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.5.926 · Cited by 453
Pérez-Schael, I., Guntiñas, M. J., Pérez, M., Pagone, V., Rojas, A. M., González, R., Cunto, W., Hoshino, Y., & Kapikian, A. Z. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710233371701 · Cited by 338
Immunity and correlates of protection for rotavirus vaccines
Franco, M. A., Angel, J., & Greenberg, H. B. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.12.048 · Cited by 268
TRIAL OF AN ATTENUATED BOVINE ROTAVIRUS VACCINE (RIT 4237) IN GAMBIAN INFANTS
Hanlon, P., Marsh, V., Shenton, F., Jobe, O., Hayes, R., Whittle, H. C., Hanlon, L., Byass, P., Hassan-King, M., Sillah, H., et al. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90649-0 · Cited by 212
Lanata, C. F., Midthun, K., Black, R. E., Butrón, B., Huapaya, A., Penny, M. E., Ventura, G., Gil, A., Jett‐Goheen, M., & Davidson, B. L. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.2.268 · Cited by 121
Bahl, R., Ray, P., Subodh, S., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/431497 · Cited by 118
Lagos, R., Fasano, A., Wasserman, S. S., Prado, V., Martin, O. S., Abrego, P. L., Losonsky, G. A., Alegria, S., & Levine, M. M. (1999) · The Journal of Infectious Diseases · doi:10.1086/315051 · Cited by 108
Enteric infections and the vaccines to counter them: Future directions
Levine, M. M. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.03.039 · Cited by 91
Hallander, H. O., Paniagua, M., Espinoza, F., Askelöf, P., Corrales, E., Ringman, M., & Storsæter, J. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00348-1 · Cited by 84
Bresee, J., Parashar, U. D., Widdowson, M., Gentsch, J. R., Steele, A. D., & Glass, R. I. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000186295.18969.e6 · Cited by 78
Combined vaccination with live oral polio vaccine and the bovine rotavirus RIT 4237 strain
Vodopija, I., Baklaić, Ž., Vlatkovic, R., Bogaerts, H. H., Delem, A., & Andre, F. E. (1986) · Vaccine · doi:10.1016/0264-410x(86)90135-0 · Cited by 50
Migasena, S., Simasathien, S., Samakoses, R., Pitisuttitham, P., Saengaroon, P., van Steenis, G., Beuvery, E. C., Bugg, H. C., Bishop, R. F., Davidson, B. L., et al. (1995) · Vaccine · doi:10.1016/0264-410x(95)93131-r · Cited by 44
Satten, G. A., & Kupper, L. L. (1990) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(90)90056-u · Cited by 17
Cited by
Tate, J. E., Burton, A. H., Boschi-Pinto, C., Steele, A. D., Duque, J., & Parashar, U. D. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70253-5 · Cited by 1,277
Zaman, K., Anh, D. D., Victor, J. C., Shin, S., Yunus, M., Dallas, M. J., Podder, G., Thiem, V. D., Mai, L. T. P., Luby, S. P., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60755-6 · Cited by 824
Effect of Rotavirus Vaccination on Death from Childhood Diarrhea in Mexico
Richardson, V., Hernandez-Pichardo, J., Quintanar-Solares, M., Esparza-Aguilar, M., Johnson, B., Gomez-Altamirano, C. M., Parashar, U., & Patel, M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0905211 · Cited by 373
Self-citationdo Carmo, G. M. I., Yen, C., Cortes, J., Siqueira, A. A., de Oliveira, W. K., Cortez-Escalante, J. J., Lopman, B., Flannery, B., de Oliveira, L. H., Hage Carmo, E., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001024 · Cited by 260
Self-citationGerner-smidt, P., Hyyti�-trees, E., & Rota, P. A. (2011) · Manual of Clinical Microbiology · doi:10.1128/9781555816728.ch8 · Cited by 259
Metadata
- Authors
- Patel, M.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2009-06-03
- Volume
- 301
- Issue
- 21
- Pages
- 2243
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2100178369
- Cited by
- 254
- References
- 24
- FWCI
- 23.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.